
Evestra, Inc.: A US-based pharmaceutical company specializing in short and long-term female healthcare products.
Evestra, Inc., founded in 2008 and based in San Antonio, United States, is a pharmaceutical company dedicated to innovating and improving female healthcare. The company's core mission is to enhance women's health and well-being through the development and commercialization of both short-term and long-term therapeutic products. Evestra focuses on key areas such as fertility control, endometriosis, and uterine fibroids, aiming to provide effective solutions for these significant health issues.
Evestra has garnered attention for its specialized research and development in women's health. The company collaborates with notable researchers and institutions to advance its mission. Among its key achievements are the development of innovative treatments that address unmet medical needs in female healthcare. Evestra's impact lies in its commitment to improving the quality of life for women through cutting-edge pharmaceutical solutions.

Oviva Therapeutics
ovivatx.com

Estrigenix Therapeutics
estrigenix.com

Elastrin Therapeutics
elastrin.com

Cortria

EicOsis
eicosis.com

Athena Feminine Technologies

EvoAktiv
evoagtec.com

Spes Pharmaceuticals
spespharma.com

Eolo Pharma
eolo-pharma.com

Hera Biotech
herabiotech.com

EIR Pharmaceuticals

Bryn Pharma
brynpharma.com

Elgia Therapeutics

EndoCellutions
endocellutions.com

Pharmatrophix
pharmatrophix.com
Companies similar to Evestra include Oviva Therapeutics, Estrigenix Therapeutics, Elastrin Therapeutics and Cortria.
Evestra was founded in 2007.
Evestra's headquarters is located in San Antonio, TX, US.
Evestra's most recent funding round was for $1.8M (USD) in December 2009.
As of Dec 14, 2009, Evestra has raised a total of $1.8M (USD).
Evestra has 9 employees as of Feb 5, 2024.